Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium-Reference-Cited by-同舟云学术

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium

Published:2013-06-29 Issue:11 Volume:60 Page:1801-1808
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Maurer Barry J.¹²³,Kang Min H.³⁴,Villablanca Judith G.⁵,Janeba Jitka⁶,Groshen Susan⁷,Matthay Katherine K.⁸,Sondel Paul M.⁹,Maris John M.¹⁰¹¹,Jackson Hollie A.¹²,Goodarzian Fariba¹²,Shimada Hiroyuki¹³,Czarnecki Scarlett¹⁴,Hasenauer Beth¹⁴,Reynolds C. Patrick¹²³,Marachelian Araz⁵

Affiliation:

1. Department of Cell Biology & Biochemistry; Texas Tech University Health Sciences Center; Lubbock Texas

2. Department of Pediatrics; Texas Tech University Health Sciences Center; Lubbock Texas

3. Department of Medicine; Texas Tech University Health Sciences Center; Lubbock Texas

4. Department of Pharmacology; Texas Tech University Health Sciences Center; Lubbock Texas

5. Department of Pediatrics; Keck School of Medicine, University of Southern California; Los Angeles California

6. Saban Research Institute; Keck School of Medicine, University of Southern California; Los Angeles California

7. Department of Statistics; Keck School of Medicine, University of Southern California; Los Angeles California

8. Department of Pediatrics; University of California San Francisco School of Medicine; San Francisco California

9. Paul P. Carbone Comprehensive Cancer Center; University of Wisconsin; Madison Wisconsin

10. Division of Oncology and Center for Childhood Cancer Research; Children's Hospital of Philadelphia, University of Pennsylvania; Philadelphia Pennsylvania

11. School of Medicine and Abramson Family Cancer Research Institute; Philadelphia Pennsylvania

12. Department of Radiology; Keck School of Medicine, University of Southern California; Los Angeles California

13. Department of Pathology; Keck School of Medicine, University of Southern California; Los Angeles California

14. New Approaches to Neuroblastoma Therapy (NANT) Consortium Operations Center; Childrens Hospital Los Angeles; Los Angeles California

Funder

National Cancer Institute, Developmental Therapeutics Program, Rapid Access to Intervention Development Program

The Cancer Prevention and Research Institute of Texas

The Children's Neuroblastoma Cancer Foundation

Alex's Lemonade Stand Foundation

Children's Neuroblastoma Cancer Foundation

Pediatric Cancer Research Group

Dougherty Family Foundation

Evan T. J. Dunbar Neuroblastoma Foundation

Douglass Michael Fuller Foundation

Neuroblastoma Children's Cancer Society

The University of Southern California,Childrens Hospital Los Angeles Institute for Pediatric Research

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24643/fullpdf

Reference42 articles.

1. Synthetic retinoid fenretinide is effective against a human ovarian carcinoma xenograft and potentiates cisplatin activity;Formelli;Cancer Res,1993

2. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid;Delia;Cancer Res,1993

3. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines;Zou;Clin Cancer Res,1998

4. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)-retinamide in neuroblastoma cell lines;Maurer;J Natl Cancer Inst,1999

5. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells;Oridate;J Natl Cancer Inst,1997

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Biological Evaluations of Granulatamide B and its Structural Analogues;Current Medicinal Chemistry;2024-08

2. The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics;Vaccines;2024-08-01

3. Attempts to Improve Lipophilic Drugs’ Solubility and Bioavailability: A Focus on Fenretinide;Pharmaceutics;2024-04-24

4. Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects;Cancers;2024-01-26

5. Development and Challenges of Synthetic Retinoid Formulations in Cancer;Current Drug Delivery;2023-11